Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Clinical trial NCT01083602 · COMPLETED
Trial details
- NCT number
- NCT01083602
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.